Truist raises Nvidia stock price target on inference demand drivers By Investing.com

Truist raised its NVDA price target to $287 (from $283) after reviewing Nvidia’s GTC presentations and datacenter backlog, joining other firms that have raised or reiterated Buy/Outperform calls. Multiple analysts set targets between $275 and $325 (Rosenblatt $325, Wolfe $275, Bernstein $300) and cited up to $1 trillion in cumulative revenue/order visibility for Blackwell and Rubin products through 2025–2027. InvestingPro data shows 33 analysts have recently revised earnings estimates upward, and firms highlighted improved revenue visibility driven by Nvidia’s evolving product portfolio and tokenomics.

Analysis

Nvidia’s messaging is creating durable demand visibility that flows downstream to server OEMs and memory/fab suppliers; that means companies like SMCI will likely see outsized near-term revenue capture as customers choose turnkey procurement to shorten deployment lead times. Tight wafer and HBM capacity acts as a choke-point: fabs (TSMC/Samsung) and memory vendors can maintain pricing power for 12–24 months, which amplifies margin capture for system integrators in the order-fulfillment window.

Key catalysts and risks separate into short and medium horizons. In the next days–weeks, sentiment from the conference and order-book color will drive volatility; in months, real revenue conversion depends on wafer-scheduling updates and any export-control headlines—either can flip consensus revenue timelines. A longer 12–24 month risk is structural substitution by hyperscalers (in-house accelerators) or a faster-than-expected capacity add from fabs that reduces pricing power and compresses margins.

Market positioning appears to assume near-complete conversion of backlog into near-term revenue—an implicit earnings certainty that is fragile. Second-order effects: used GPU availability will remain suppressed, keeping demand for new systems high, but that also increases exposure to supply disruptions (shipping, logistics, yielding problems) which would delay revenue recognition while leaving inventory risk with OEMs.

Given this profile, prefer defined-risk exposures and supply-chain plays over outright leverage on component hype. Position sizing should bias toward short-dated event hedges and 6–18 month option structures that capture upside while controlling the tail if orders reprice or get delayed.

Key Decisions for Investors

• Buy NVDA 6–9 month call debit spread (size 1–2% NAV): enter on IV rank <50 or any 5–10% post-GTC pullback. Rationale: capture continued product-cycle re-rating with capped downside; target 30–50% return, max loss = premium paid.
• Overweight SMCI (size 1–2% NAV, 6–12 month horizon): buy equity to capture systems revenue during backlog conversion. Set stop-loss at 20% below entry and target 40–80% upside if OEM bookings translate to shipments.
• Pair trade: Long SMCI (0.8% NAV) / Short NVDA (0.6% NAV) for 6–12 months — hedge aims to capture systems-level demand even if component multiple mean-reverts. Target +20–30% net return if NVDA derates 15% or SMCI outperforms by 30%; cut if both rise >20%.
• Event hedge: Buy 3–6 month NVDA put spread (size 0.5–1% NAV) to protect against export-control or order-slip headlines; fund by selling short-dated calls up to IV-neutral. Expect cost <1.5% NAV for ~20% downside protection; use as tactical insurance around quarterly updates.